AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913,749 | -2.1% | 392,167 | 0.0% | 0.05% | +1.9% |
| Q2 2023 | $933,357 | +129173.8% | 392,167 | 0.0% | 0.05% | +8.3% |
| Q1 2023 | $722 | -3.1% | 392,167 | 0.0% | 0.05% | -4.0% |
| Q4 2022 | $745 | -99.9% | 392,167 | 0.0% | 0.05% | -15.3% |
| Q3 2022 | $839,000 | -24.4% | 392,167 | 0.0% | 0.06% | -29.8% |
| Q2 2022 | $1,110,000 | -32.1% | 392,167 | 0.0% | 0.08% | -33.3% |
| Q1 2022 | $1,635,000 | -19.7% | 392,167 | 0.0% | 0.13% | +4.1% |
| Q4 2021 | $2,035,000 | -20.8% | 392,167 | 0.0% | 0.12% | +16.3% |
| Q3 2021 | $2,569,000 | -1.3% | 392,167 | 0.0% | 0.10% | +18.2% |
| Q2 2021 | $2,604,000 | +7.6% | 392,167 | -7.1% | 0.09% | +63.0% |
| Q1 2021 | $2,419,000 | -35.9% | 422,167 | 0.0% | 0.05% | -40.0% |
| Q4 2020 | $3,774,000 | -23.2% | 422,167 | 0.0% | 0.09% | -52.4% |
| Q3 2020 | $4,914,000 | -36.1% | 422,167 | -12.0% | 0.19% | -35.7% |
| Q2 2020 | $7,694,000 | +167.6% | 479,988 | 0.0% | 0.29% | +119.4% |
| Q1 2020 | $2,875,000 | -54.6% | 479,988 | 0.0% | 0.13% | -47.0% |
| Q4 2019 | $6,336,000 | +6.3% | 479,988 | 0.0% | 0.25% | -30.3% |
| Q3 2019 | $5,961,000 | -47.1% | 479,988 | -31.4% | 0.36% | -43.9% |
| Q2 2019 | $11,270,000 | -57.9% | 700,000 | -17.6% | 0.65% | -64.2% |
| Q1 2019 | $26,750,000 | -34.2% | 850,000 | -35.9% | 1.81% | -31.6% |
| Q3 2018 | $40,673,000 | -0.5% | 1,326,136 | -13.1% | 2.64% | -12.6% |
| Q2 2018 | $40,870,000 | – | 1,525,587 | – | 3.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |